Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.

Duda SN, Farr AM, Lindegren ML, Blevins M, Wester CW, Wools-Kaloustian K, Ekouevi DK, Egger M, Hemingway-Foday J, Cooper DA, Moore RD, McGowan CC, Nash D; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.

J Int AIDS Soc. 2014 Dec 15;17:19045. doi: 10.7448/IAS.17.1.19045. eCollection 2014.

2.

Continuous increase of cardiovascular diseases, diabetes, and non-HIV related cancers as causes of death in HIV-infected individuals in Brazil: an analysis of nationwide data.

Paula AA, Schechter M, Tuboi SH, Faulhaber JC, Luz PM, Veloso VG, Moreira RI, Grinsztejn B, Harrison LH, Pacheco AG.

PLoS One. 2014 Apr 11;9(4):e94636. doi: 10.1371/journal.pone.0094636. eCollection 2014.

3.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team.

N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.

4.

Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil.

Pacheco AG, Saraceni V, Tuboi SH, Lauria LM, Moulton LH, Faulhaber JC, King B, Golub JE, Durovni B, Cavalcante S, Harrison LH, Chaisson RE, Schechter M.

AIDS Res Hum Retroviruses. 2011 Jan;27(1):25-8. doi: 10.1089/aid.2010.0089. Epub 2010 Oct 7.

5.

Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study).

Nunes EP, Santini de Oliveira M, Merçon M, Zajdenverg R, Faulhaber JC, Pilotto JH, Ribeiro JE, Norton M, Schechter M.

HIV Clin Trials. 2009 Nov-Dec;10(6):368-74. doi: 10.1310/hct1006-368.

PMID:
20133267
6.

Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil.

Pacheco AG, Tuboi SH, May SB, Moreira LF, Ramadas L, Nunes EP, Merçon M, Faulhaber JC, Harrison LH, Schechter M.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):624-30. doi: 10.1097/QAI.0b013e3181a4ecf5.

7.

Barriers to recruit female commercial sex workers for HIV vaccine trials: the Rio de Janeiro experience.

Barroso PF, de Souza MB, do Lago RF, Pedrosa J, Yoshida CB, Faulhaber JC, Costa MD, Schechter M.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):116-7. doi: 10.1097/QAI.0b013e31818d5e3f. No abstract available.

PMID:
19092453
8.

Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil.

Pacheco AG, Saraceni V, Tuboi SH, Moulton LH, Chaisson RE, Cavalcante SC, Durovni B, Faulhaber JC, Golub JE, King B, Schechter M, Harrison LH.

Am J Epidemiol. 2008 Dec 1;168(11):1326-32. doi: 10.1093/aje/kwn249. Epub 2008 Oct 9.

9.

Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil.

Pacheco AG, Tuboi SH, Faulhaber JC, Harrison LH, Schechter M.

PLoS One. 2008 Jan 30;3(1):e1531. doi: 10.1371/journal.pone.0001531.

10.

Effectiveness of highly active antiretroviral therapy using non-brand name drugs in Brazil.

May SB, Barroso PF, Nunes EP, Barcaui HS, Almeida MM, Costa MD, Faulhaber JC, Santoro-Lopes G, Schechter M.

Braz J Med Biol Res. 2007 Apr;40(4):551-5.

11.

Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil.

Djomand G, Duerr A, Faulhaber JC, Struchiner CJ, Pacheco AG, Barroso PF, Melo MF, Schechter M.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):401-4.

PMID:
17031316
12.

Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.

Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, Moore RD, Chaisson RE.

Am J Respir Crit Care Med. 2006 Apr 15;173(8):922-6. Epub 2006 Feb 10.

13.

Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. Projeto Praço Onze Study Group.

Schechter M, do Lago RF, de Melo MF, Sheppard HW, Guimarães NC, Moreira RI, Faulhaber JC, Batista S, Harrison LH.

J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):175-7.

PMID:
10935694
14.

Vibronic coupling in C60 and C603-

Faulhaber JC, Ko DY, Briddon PR.

Phys Rev B Condens Matter. 1993 Jul 1;48(1):661-664. No abstract available.

PMID:
10006835

Supplemental Content

Loading ...
Support Center